Table 2.
Effect of Plin2 modulation on triacylglycerol FA profile in tibialis anterior muscle (g/100 g of total triacylglycerol fatty acids)
| Plin2 down‐regulation experiment | Plin2 overexpression experiment | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Scramble | shPLIN2 | SEM | P‐value | Control | overPLIN2 | SEM | P‐value | ||
| C10:0 | 0.27 | 0.90 | 0.09 | <0.01 | 0.44 | 0.37 | 0.11 | 0.40 | |
| C12:0 | 0.72 | 3.46 | 1.33 | 0.19 | 3.34 | 1.03 | 0.27 | 0.25 | |
| C14:0 | 2.88 | 5.59 | 0.53 | 0.01 | 3.82 | 4.52 | 0.26 | 0.08 | |
| C14:1t9 | 0.28 | 0.61 | 0.05 | <0.01 | 0.24 | 0.20 | 0.12 | 0.62 | |
| C15:0anteiso | 0.15 | 0.40 | 0.08 | 0.07 | 0.13 | 0.33 | 0.01 | 0.01 | |
| C15:0 | 0.64 | 1.11 | 0.14 | 0.05 | 0.68 | 0.70 | 0.05 | 0.12 | |
| C16:0 | 25.45 | 31.96 | 0.81 | <0.01 | 30.63 | 29.35 | 0.17 | 0.05 | |
| C16:1c7 | 0.96 | 1.36 | 0.32 | 0.41 | 0.53 | 1.07 | 0.01 | 0.02 | |
| C16:1c9 | 8.22 | 4.34 | 0.41 | <0.01 | 2.89 | 5.15 | 0.04 | 0.02 | |
| C17:0anteiso | 0.12 | 0.23 | 0.02 | <0.01 | 0.58 | 0.40 | 0.06 | 0.11 | |
| C17:0 | 1.46 | 1.90 | 0.26 | 0.28 | 1.69 | 1.19 | 0.28 | 0.49 | |
| C18:0 | 5.58 | 13.47 | 1.15 | <0.01 | 14.53 | 10.03 | 0.19 | 0.10 | |
| C18:1t6–8 | 0.18 | 0.16 | 0.08 | 0.83 | 0.38 | 0.37 | 0.05 | 0.01 | |
| C18:1t9 | 0.32 | 0.41 | 0.16 | 0.70 | 0.20 | 0.19 | 0.04 | 0.03 | |
| C18:1t10 | 0.26 | 0.28 | 0.06 | 0.82 | 0.20 | 0.17 | 0.05 | 0.26 | |
| C18:1t11 | 0.14 | 0.49 | 0.19 | 0.24 | 0.46 | 0.41 | 0.21 | 0.51 | |
| C18:1t12 | 0.27 | 0.77 | 0.32 | 0.32 | 0.36 | 0.46 | 0.11 | 0.15 | |
| C18:1c9 | 25.50 | 16.21 | 1.46 | <0.01 | 30.32 | 36.52 | 0.70 | 0.02 | |
| C18:1c11 | 2.12 | 1.16 | 0.12 | <0.01 | 1.22 | 1.64 | 0.04 | 0.04 | |
| C18:2n6 | 19.80 | 9.25 | 1.24 | <0.01 | 2.48 | 2.88 | 0.12 | 0.03 | |
| C20:0 | 0.04 | 0.21 | 0.06 | 0.05 | 0.38 | 0.23 | 0.03 | 0.01 | |
| C18:3n6 | 0.18 | 0.39 | 0.06 | 0.05 | 0.10 | 0.07 | 0.02 | 0.36 | |
| C18:3n3 | 1.17 | 0.62 | 0.05 | <0.01 | 0.40 | 0.53 | 0.01 | 0.03 | |
| C20:3n6 | 0.43 | 1.59 | 0.18 | <0.01 | 0.21 | 0.27 | 0.11 | 0.41 | |
| C20:4n6 | 0.18 | 0.96 | 0.26 | 0.05 | 2.07 | 1.14 | 0.04 | 0.03 | |
| C20:5n3 | 0.13 | 0.25 | 0.07 | 0.04 | 0.19 | 0.19 | 0.05 | 0.21 | |
| C24:0 | 0.87 | 0.47 | 0.13 | 0.05 | 0.40 | 0.46 | 0.22 | 0.45 | |
| C22:5n3 | 0.25 | 0.47 | 0.08 | 0.02 | 1.04 | 0.90 | 0.08 | 0.15 | |
| SFA | 38.45 | 60.12 | 3.10 | <0.01 | 56.63 | 48.18 | 0.83 | 0.08 | |
| PUFA | 24.49 | 14.74 | 1.45 | <0.01 | 6.49 | 5.57 | 0.18 | 0.11 | |
| MUFA | 38.24 | 25.77 | 2.01 | <0.01 | 36.78 | 46.16 | 0.91 | 0.02 | |
| MCFA | 41.15 | 51.85 | 1.79 | <0.01 | 44.97 | 44.28 | 1.04 | 0.07 | |
| LCFA | 55.51 | 43.19 | 1.83 | <0.01 | 50.64 | 52.85 | 1.35 | 0.02 | |
| VLCFA | 4.51 | 5.57 | 0.56 | 0.22 | 4.30 | 2.78 | 0.28 | 0.41 | |
LCFA, long‐chain fatty acid (17 < C < 20); MCFA, medium‐chain fatty acid (10 < C < 18); MUFA, monounsaturated fatty acid; PUFA, polyunsaturated fatty acid; SEM, standard error of the mean; SFA, saturated fatty acid; VLCFA, very‐long‐chain fatty acid (C < 19).